China (Mainland)
(4S)-3-[5-(4-fluorophenyl)1,5-dioxophentyl]-4-phenyl-2-oxazolidinone CAS NO.189028-93-1
- FOB Price: USD: /Kilogram Get Latest Price
- Min.Order: 10 Kilogram
- Payment Terms: D/P,T/T
- Available Specifications:
Purity>99%(0-500)Kilogram
- Product Details
Keywords
- Ezetimibe
- Ezetimibe Intermediate
- GMP, ISO
Quick Details
- ProName: (4S)-3-[5-(4-fluorophenyl)1,5-dioxophe...
- CasNo: 189028-93-1
- Molecular Formula: C20H18FNO4
- Appearance: white or almost white powder
- Application: key intermediates of Ezetimibe
- DeliveryTime: 5days
- PackAge: 25kgs/drum
- ProductionCapacity: 1000 Metric Ton/Month
- Purity: 98.5%
- Transportation: By Air/By Sea
- LimitNum: 10 Kilogram
- Moisture Content: <0.5%
- Impurity: <0.5%
- Water: 0.06%
- Residue on ignition: 0.1%
- Enantiomer: 0.012%
- Dichloromethane: ND
- Isopropanol: 0.07%
- Single impurity: 0.07%
- Total impurities: 0.27%
- Content: 99.4%
Superiority
YILING WANYANG HENGSHUI PHARMACEUTICAL CO., LTD. is based on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD., having a stance in the domestics, and heading towards the international. Striving to establish and form a comprehensive management system throughout the whole product life cycle, including product R & D, technology transfer, large-scale production and marketing, and build a production and quality control system in line with EMA, FDA and other international standards. Based on high standards, high quality, high efficiency and well-run operation system, Wanyang Hengshui actively seeks to carry out diversified cooperation with domestic and foreign enterprises. Our business objectives focus on: R&D of small molecule drugs, large scale production, marketing, CDMO, CMO, etc.
Details
YILING WANYANG HENGSHUI PHARMACEUTICAL CO., LTD. is the wholly-owned subsidiary of
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD., located in High-Tech Industrial Development Zone, Hengshui City, Hebei Province, total area: 338000m2, with completely new constructions; Aiming at: establishing a Global-oriented Research Center, a Manufacturing & Marketing base of APIs&FDFs, and CDMO platform, which is complying with international standards. Wanyang Hengshui is responsible for the future development of chemical pharmaceutical sector of Yiling group.
YILING WANYANG HENGSHUI PHARMACEUTICAL CO., LTD. is based on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD., having a stance in the domestics, and heading towards the international. Striving to establish and form a comprehensive management system throughout the whole product life cycle, including product R & D, technology transfer, large-scale production and marketing, and build a production and quality control system in line with EMA, FDA and other international standards. Based on high standards, high quality, high efficiency and well-run operation system, Wanyang Hengshui actively seeks to carry out diversified cooperation with domestic and foreign enterprises. Our business objectives focus on: R&D of small molecule drugs, large scale production, marketing, CDMO, CMO, etc.
